首页> 外文期刊>Cancer prevention research. >Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma
【24h】

Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma

机译:全面测序验证了皮肤鳞状细胞癌的预防和治疗临床前小鼠模型

获取原文
获取原文并翻译 | 示例
       

摘要

Cutaneous squamous cell carcinomas (cSCC) are among the most common and highly mutated human malignancies. Solar UV radiation is the major factor in the etiology of cSCC. Whole-exome sequencing of 18 microdissected tumor samples (cases) derived from SKH-1 hairless mice that had been chronically exposed to solar-simulated UV (SSUV) radiation showed a median point mutation (SNP) rate of 155 per Mb. The majority (78.6%) of the SNPs are C.G>T.A transitions, a characteristic UVR-induced mutational signature. Direct comparison with human cSCC cases showed high overlap in terms of both frequency and type of SNP mutations. Mutations in Trp53 were detected in 15 of 18 (83%) cases, with 20 of 21 SNP mutations located in the protein DNA-binding domain. Strikingly, multiple nonsynonymous SNP mutations in genes encoding Notch family members (Notch1-4) were present in 10 of 18 (55%) cases. The histopathologic spectrum of the mouse cSCC that develops in this model resembles very closely the spectrum of human cSCC. We conclude that the mouse SSUV cSCCs accurately represent the histopathologic and mutational spectra of the most prevalent tumor suppressors of human cSCC, validating the use of this preclinical model for the prevention and treatment of human cSCC. (C) 2016 AACR.
机译:皮肤鳞状细胞癌(cSCC)是人类最常见和高度变异的恶性肿瘤之一。太阳紫外线辐射是引起cSCC的主要因素。来自长期暴露于太阳模拟紫外线(SSUV)辐射的SKH-1无毛小鼠的18个显微解剖肿瘤样本(病例)的全外显子组测序显示,中位点突变(SNP)率为155/Mb。大多数(78.6%)的SNP是C.G>T.A转换,这是一种典型的紫外线诱导的突变特征。与人类cSCC病例的直接比较显示,SNP突变的频率和类型都存在高度重叠。18例患者中有15例(83%)检测到Trp53突变,21例SNP突变中有20例位于蛋白质DNA结合域。引人注目的是,编码Notch家族成员(Notch1-4)的基因中有10个(55%)存在多个非同义SNP突变。在该模型中形成的小鼠cSCC的组织病理学谱与人类cSCC的谱非常相似。我们得出结论,小鼠SSUV-cSCC准确地代表了人类cSCC最常见的肿瘤抑制因子的组织病理学和突变谱,验证了这种临床前模型在人类cSCC预防和治疗中的应用。(C) 2016年AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号